|
Immunogenicity and safety of GSK Biologicals’ IPV (Poliorix™) in infants |
Poliomyelitis Vaccine (Inactivated) |
112679 |
NCT01021293 2011-003167-30 |
Poliomyelitis |
Phase 3 |
|
|
|
|
An annotated case report form is not available for this study. A blank case report form will be provided. |
February 2015 |